Uçar İsmail, Turgay Batuhan, Küçükşahin Orhan, Özkan Uçar Esma, Turgay Murat
Turk J Med Sci. 2018 Dec 12;48(6):1104-1108. doi: 10.3906/sag-1708-52.
BACKGROUND/AIM: The aim of the study was to investigate the effect of systemic sclerosis (SSc) on quality of life and sexual function in female patients.
The study included 30 sexually active female patients with SSc and 30 healthy control subjects. For all participants in both the patient and control groups, the female sexual index and SF-36 forms were completed and a detailed medical and sexual history was taken.
The mean age was 45.03 ± 9.22 years in the SSc group and 44.6 ± 11.52 years in the control group (P = 0.87). The SF-36 scores in the patient group were significantly lower than those in the control group. Sexual dysfunction was found in 26/30 (86.6%) of the SSc patients and in 6/30 (20%) of the control group (P = 0.0001). Significant differences were determined between the groups with respect to sexual desire, arousal, lubrication, orgasm, sexual satisfaction, and pain. There was no significant relationship between the subgroups of SSc patients, duration of disease, lung involvement, and FSFI scores.
Sexual dysfunction and lower health quality are common problems in female patients with systemic sclerosis.
背景/目的:本研究旨在调查系统性硬化症(SSc)对女性患者生活质量和性功能的影响。
本研究纳入了30名有性活动的SSc女性患者和30名健康对照者。患者组和对照组的所有参与者均完成了女性性功能指数和SF - 36量表,并采集了详细的医疗和性病史。
SSc组的平均年龄为45.03±9.22岁,对照组为44.6±11.52岁(P = 0.87)。患者组的SF - 36评分显著低于对照组。26/30(86.6%)的SSc患者存在性功能障碍,对照组为6/30(20%)(P = 0.0001)。两组在性欲、性唤起、润滑、性高潮、性满意度和疼痛方面存在显著差异。SSc患者的亚组、病程、肺部受累情况与女性性功能指数(FSFI)评分之间无显著关系。
性功能障碍和较低的健康质量是系统性硬化症女性患者的常见问题。